Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revefenacin (TD-4208) QD vs BID in COPD
NCT02109172Phase 2Completed
- Sponsor
- Mylan
- Start
- Apr 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of revefenacin in chronic obstructive pulmonary disease (COPD), sponsored by Mylan. Started Apr 2014; status: completed.
02
Drugs
revefenacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02109172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02109172.